CAS: 83465-22-9; (1S,2S,3R,4S,5S)-5-Amino-1-(Hydroxymethyl)Cyclohexane-1,2,3,4-Tetraol

该化合物是一种化学改良的异硫醇衍生物,可能用于血液生物学和药用化学.其独特的结构是C-2位置的氢氧甲基组和C-4位置的氨基组,将其与天然的无氮基类区分开来,从而能够与生物目标进行选择性互动.该化合物由于其立体化学结构和功能组的多功能组,可作为合成甘基丁酸抑制剂或合成物的宝贵中间体.其稳定性和水溶性进一步提高其在生物化学研究中的效用.研究表明,在调制酶途径方面,尽管需要开展进一步的调查,以充分阐明其药理特性.

结构式图片

上下游产品

-1,2,3,4-cyclohexanetetrol2,3,4-tri-O-benzyl-5-amino-1-C-(benzyloxy)methyl-1,2,3,4-cyclohexanetetrol -6,7,8-trihydroxy-1-(hydroxymethyl)-3-oxo-2-oxa-4-azabicyclononane1S-(endo,exo,endo)-6,7,8-trihydroxy-1-(hydroxymethyl)-3-oxo-2-oxa-4-azabicyclo3.3.1nonane nonane1-(bromomethyl)-6,7,8-trihydroxy-3-oxo-2-oxa-4-azabicyclo3.3.1nonane nonane6,7,8-triacetoxy-1-(bromomethyl)-3-oxo-2-oxa-4-azabicyclo3.3.1nonaneN-(3-pyridylmethyl)valiolamine N-thenylvaliolamine voglibose N-cyclohexylvaliolamine

合成工艺路线路线简述

  • 1054636-37-1 = 83465-22-9
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol,Water; 24 H,Rt
    标题:Improved Stereoselective Syntheses Of (+)-Valiolamine And (+)-Valienamine Starting From (-)-Shikimic Acid
    作者:Li,Fenglei; Et Al
    参考文献:Chinese Journal Of Chemistry 日期:2017 卷标:35(4) 页码:457-464]

    118014-37-2 = 83465-22-9
    反应条件:1.1 Reagents: Barium Hydroxide Solvents: Water; 8 H,80 °C; 80 °C -> Rt1.2 Reagents: Carbon Dioxide; Rt1.3 Reagents: Amberlite Cg 50 Solvents: Water; 5 H,Rt1.4 Reagents: Dowex 50W Solvents: Water; 2 H,Rt
    标题:Diastereospecific Epoxidation And Highly Regioselective Ring-Opening Of (+)-Valienamine: Practical Synthesis Of (+)-Valiolamine
    作者:Ji,Li; Et Al
    参考文献:Tetrahedron 日期:2013 卷标:69(34) 页码:7031-7037]

    = 83465-22-9
    反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Water; 3 H,80 °C
    标题:Convenient Synthesis Of (+)-Valiolamine And (-)-1-Epi-Valiolamine From (-)-Vibo-Quercitol
    作者:Ogawa,Seiichiro; Et Al
    参考文献:Organic & Biomolecular Chemistry 日期:2004 卷标:2(6) 页码:884-889]

    = 83465-22-9
    反应条件:1.1 Reagents: Acetic Acid,Potassium Bromide Solvents: Tetrahydrofuran; 0 - 5 °C; 18 H,Rt1.2 Reagents: Sodium Bicarbonate; Ph 7,Rt2.1 Reagents: Sodium Borohydride Solvents: Methanol; 8 H,Rt2.2 Reagents: Acetic Acid; Ph 6 - 7,Rt3.1 Reagents: Barium Hydroxide Solvents: Water; 8 H,80 °C; 80 °C -> Rt3.2 Reagents: Carbon Dioxide; Rt3.3 Reagents: Amberlite Cg 50 Solvents: Water; 5 H,Rt3.4 Reagents: Dowex 50W Solvents: Water; 2 H,Rt
    标题:Diastereospecific Epoxidation And Highly Regioselective Ring-Opening Of (+)-Valienamine: Practical Synthesis Of (+)-Valiolamine
    作者:Ji,Li; Et Al
    参考文献:Tetrahedron 日期:2013 卷标:69(34) 页码:7031-7037]

    = 83465-22-9
    反应条件:1.1 Reagents: Lithium,Ammonia Solvents: Tetrahydrofuran; -78 °C; 3 H,-60 °C1.2 Reagents: Water; -60 °C; -60 °C -> Rt1.3 Reagents: Lithium Hydroxide Solvents: Ethanol,Water; Rt; 1 H,80 °C1.4 Reagents: Acetic Acid Solvents: Water; 18 H,50 °C
    标题:A C2-Symmetric Pool Based Flexible Strategy: An Enantio-Convergent Synthesis Of (+)-Valiolamine And (+)-Valienamine
    作者:Lo,Hong-Jay; Et Al
    参考文献:European Journal Of Organic Chemistry 日期:2012 卷标:2012(14) 页码:2780-2785]

    = 83465-22-9
    反应条件:1.1 Reagents: Barium Hydroxide Solvents: Water
    标题:Stereoselective Conversion Of Valienamine And Validamine Into Valiolamine
    作者:Horii,Satoshi; Et Al
    参考文献:Carbohydrate Research 日期:1985 卷标:140(2) 页码:185-200]

    1054636-37-1 = 83465-22-9
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol,Water; 24 H,Rt
    标题:Total Syntheses Of (+)-Valiolamine And (-)-1-Epi-Valiolamine From Naturally Abundant (-)-Shikimic Acid
    作者:Quan,Na; Et Al
    参考文献:European Journal Of Organic Chemistry 日期:2013 卷标:2013(28) 页码:6389-6396]

    1060713-64-5 = 83465-22-9
    反应条件:1.1 Reagents: Trifluoroacetic Acid Solvents: Dichloromethane; 2 D,Rt
    标题:Intramolecular Direct Aldol Reactions Of Sugar Diketones: Syntheses Of Valiolamine And Validoxylamine G
    作者:Shing,Tony K. M.; Et Al
    参考文献:Organic Letters 日期:2008 卷标:10(18) 页码:4137-4139]

    85281-06-7 = 83465-22-9
    反应条件:1.1 Reagents: Barium Hydroxide Solvents: Water
    标题:Stereoselective Conversion Of Valienamine And Validamine Into Valiolamine
    作者:Horii,Satoshi; Et Al
    参考文献:Carbohydrate Research 日期:1985 卷标:140(2) 页码:185-200]

    = 83465-22-9
    反应条件:1.1 Reagents: Potassium Carbonate Solvents: Methanol1.2 Reagents: Hydrogen Catalysts: Palladium Dihydroxide Solvents: Ethanol
    标题:Enantiospecific Syntheses Of Valiolamine And Its (1R),(2R),(1R,2R) Diastereomers From (-)-Quinic Acid
    作者:Shing,Tony K. M.; Et Al
    参考文献:Angewandte Chemie 日期:1995 卷标:34(15) 页码:1643-5]

    = 83465-22-9 [标题:Reaction Conditions
    标题:Inosose Derivatives As Intermediates For Valienamine And Valiolamine And A Process For Their Preparation
    参考文献:European Patent Organization]

    115250-38-9 = 83465-22-9 [标题:Reaction Conditions
    标题:Inosose Derivatives As Intermediates For Valienamine And Valiolamine And A Process For Their Preparation
    参考文献:European Patent Organization]

    = 83465-22-9
    反应条件:1.1 Reagents: Barium Hydroxide Solvents: Water
    标题:Stereoselective Conversion Of Valienamine And Validamine Into Valiolamine
    作者:Horii,Satoshi; Et Al
    参考文献:Carbohydrate Research 日期:1985 卷标:140(2) 页码:185-200
Tetra-O-Benzylvaliolamine置于palladium 10% On Activated Carbon 盐酸,氢气体系中,用 四氢呋喃,甲醇,水 作为反应溶剂,40.0 °C,294.2 Kpa 条件下,反应 4.5H,反应生成 井冈霉醇胺
参考文献: Process For The Preparation Of 1,2,3,4-Cyclohexanetetrol Derivatives[fr] Procede Pour La Preparation De Derives De 1,2,3,4-Cyclohexanetetrol
标题: Process For The Preparation Of 1,2,3,4-Cyclohexanetetrol Derivatives[fr] Procede Pour La Preparation De Derives De 1,2,3,4-Cyclohexanetetrol
摘要:本文提供了制备1,2,3,4-环己烷四醇衍生物的方法,这些衍生物是合成沃格利波糖的有用中间体;制备取代的2,3,4,5-四羟基环己酮的方法;以及制备沃格利波糖的方法.还提供了通过这些方法形成的化合物.

海关参考信息

专利信息


专利号:WO-2005049547-A1
优先权日:2003-11-21
标 题 :Process for the preparation of 1,2,3,4-cyclohexanetetrol derivatives
发明人:KHANDURI CHANDRA HAS; BABU JAYACHANDRA SURESH; RAY PURNA CHANDRA; SHAH JIGAR BHASKARBHAI; KUMAR YATENDRA
权利人:RANBAXY LAB LTD; KHANDURI CHANDRA HAS; BABU JAYACHANDRA SURESH; RAY PURNA CHANDRA; SHAH JIGAR BHASKARBHAI; KUMAR YATENDRA
摘要:Provided herein are processes for the preparation of 1,2,3,4-cyclohexanetetrol derivatives, which are useful intermediates for the synthesis of voglibose; processes for the preparation of substituted 2,3,4,5-tetrahydroxycyclohexanone; and processes for preparing voglibose. Also provided are compounds formed by such processes.

专利号:US-2007032537-A1
优先权日:2003-06-13
标题:5-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseases
发明人:SEMPLE GRAEME; GHARBAOUI TAWFIK; SHIN YOUNG-JUN; DECAIRE MARC; AVERBUJ CLAUDIA L; SKINNER PHILIP J
权利人:ARENA PHARM INC
摘要:The present invention relates to certain pyrazole carboxylic acid and ester derivatives, and pharmaceutically acceptable salts thereof, which exhibit useful pharmaceutical properties, for example as agonists for the RUP25 receptor. (I) Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the prophylaxis or treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of α-glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like the substituents are defined in claim 1.

专利号:WO-2006127595-A1
优先权日:2005-05-23
标题:5-aminopyrazole carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof
发明人:SKINNER PHILIP J; SEMPLE GRAEME; WEBB PETER
权利人:ARENA PHARM INC; SKINNER PHILIP J; SEMPLE GRAEME; WEBB PETER
摘要:The present invention relates to certain pyrazole carboxylic acid or ester derivatives of Formula (I) and pharmaceutically acceptable salts thereof which exhibit useful pharmacological properties, for example, as agonists for the GPCR referred to herein as RUP38. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, such as, dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of -glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like.

专利号:US-6538131-B1
优先权日:1999-04-19
标 题 :Synthetic process for highly functionalized carbocyclic polyols and substituted sugar analogs
发明人:AL-ABED YOUSEF; SEEPERSAUD MOHINDRA
权利人:PICOWER INST MED RES
摘要:Chemical processes for more efficient synthesis of carbocyclic polyols and substituted sugar analogs are disclosed, together with a novel class of cyclopentene polyol intermediate products and anhydro derivatives thereof.

专利号:CN-102105455-A
优先权日:2008-08-08
标题 :Stereoselective synthesis of valiolamine

专利号:WO-2010015107-A1
优先权日:2008-08-08
标题:Stereoselective synthesis of valiolamine
上海西加生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.sigachem.com
企业联系电话:18901978308👤
📞上海西加生物科技有限公司 ⚠️参考联系方式
联系人:龚经理
电话:18901978308
手机:13764598896

邮箱:grace8018@163.com
通信地址: 上海市崇明区新河镇新申路921弄2号W区175室
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市崇明区新河镇新申路921弄2号W区175室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
浙江钱江生物化学股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.qianjiangbioch.com
电话: 573-87046039👤
📞浙江钱江生物化学股份有限公司 ⚠️参考联系方式

销售电话:573-87046039
邮箱:sales@qianjiangbioch.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
常州博海威医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.bohiv.com
企业联系电话:0519-85252351👤
📞常州博海威医药科技有限公司 ⚠️参考联系方式
联系人:刘先生
电话:0519-85252351
手机:13817821051
传真:0519-85716185
邮箱:lxq@bohiv.com
通信地址: 江苏省常州市新北区春江镇玉龙北路600-1号
邮编: 213127
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省常州市新北区春江镇玉龙北路600-1号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Karade SS, Hill ML, Kiappes JL, Manne R, Aakula B, Zitzmann N, Warfield KL, Treston AM, Mariuzza RA. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity. J Med Chem. 2021 Dec 23;64(24):18010-18024. doi: 10.1021/acs.jmedchem.1c01377. Epub 2021 Dec 6. 15(7):12188-95. doi: 10.3390/ijms150712188.
3: Bin BH, Seo J, Yang SH, Lee E, Choi H, Kim KH, Cho EG, Lee TR. Novel inhibitory effect of the antidiabetic drug voglibose on melanogenesis. Exp Dermatol. 2013 Aug;22(8):541-6. doi: 10.1111/exd.12195. 81(4-5):1613-8. doi: 10.1016/j.talanta.2010.03.011. Epub 2010 Mar 19. 49(4):957-63. doi: 10.1016/j.jpba.2009.02.020. Epub 2009 Feb 27. 9(1):58-75. doi: 10.2174/156802609787354324. 10(18):4137-9. doi: 10.1021/ol801889n. Epub 2008 Aug 26. 70(3):493-7. doi: 10.1021/np068069t. Epub 2007 Mar 9. 1(1):12. doi: 10.1186/1860-5397-1-12.
10: Chen X, Zheng Y, Shen Y. Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors. Curr Med Chem. 2006;13(1):109-16. doi: 10.2174/092986706789803035. 2(6):884-9. doi: 10.1039/b314795a. Epub 2004 Feb 18. 338(20):2075-82. doi: 10.1016/s0008-6215(03)00315-x. 123(12):2733-42. doi: 10.1021/ja003643n. 2(4):457-60. doi: 10.1021/ol9913035. 59(2 Suppl):74-8. Spanish. 38(7):1970-2. doi: 10.1248/cpb.38.1970. 108(1):42-6. doi: 10.1093/oxfordjournals.jbchem.a123160. 29(6):1038-46. doi: 10.1021/jm00156a023. 38(12):1816-8. doi: 10.7164/antibiotics.38.1816. 37(11):1301-7. doi: 10.7164/antibiotics.37.1301.

合成参考文献


摘要:European Patent Application., #63456
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知